(VIANEWS) – Northeast Bank (NBN), Afya (AFYA), CrossFirst Bankshares (CFB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Northeast Bank (NBN)
24.3% sales growth and 15.96% return on equity
Northeast Bank provides personal and business banking services in Maine, the United States. The company's deposit products include demand deposit, NOW, money market, savings, certificate of deposit, and individual retirement accounts, as well as checking accounts. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, such as term loans, lines of credit and equipment, and receivables financing; consumer loans comprising mobile home and overdraft, and deposit-secured loans; and small business administration loans. In addition, the company offers telephone banking, online banking and bill payment, mobile banking, cash management, and remote deposit capture services, as well as debit and credit card, ATM, electronic transfer, and check services. It operates a network of nine branches in Western, Central, and Southern Maine. Northeast Bank was founded in 1872 and is headquartered in Portland, Maine.
Earnings Per Share
As for profitability, Northeast Bank has a trailing twelve months EPS of $5.36.
PE Ratio
Northeast Bank has a trailing twelve months price to earnings ratio of 6.8. Meaning, the purchaser of the share is investing $6.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.96%.
Moving Average
Northeast Bank’s worth is under its 50-day moving average of $37.19 and way below its 200-day moving average of $40.68.
2. Afya (AFYA)
22.7% sales growth and 12.57% return on equity
Afya (afya) lags Q1 earnings estimatesWhile Afya has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Earnings Per Share
As for profitability, Afya has a trailing twelve months EPS of $0.85.
PE Ratio
Afya has a trailing twelve months price to earnings ratio of 13.72. Meaning, the purchaser of the share is investing $13.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.57%.
Sales Growth
Afya’s sales growth is 29.8% for the present quarter and 22.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Afya’s EBITDA is 7.95.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.2%, now sitting on 2.33B for the twelve trailing months.
Yearly Top and Bottom Value
Afya’s stock is valued at $11.66 at 06:22 EST, way below its 52-week high of $17.02 and way higher than its 52-week low of $8.73.
3. CrossFirst Bankshares (CFB)
17.7% sales growth and 9.6% return on equity
CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks. The company offers commercial real estate, construction and development, 1-4 family real estate, commercial, energy, and consumer loans. It also provides a range of deposit products consisting of noninterest-bearing demand and interest-bearing deposits, which include transaction accounts, savings accounts, money market accounts, and certificates of deposit; and personal and business checking and savings accounts, as well as negotiable order of withdrawal accounts; and brokered and reciprocal deposits. In addition, the company offers international banking services; treasury management services; automated teller machine access; and mobile banking services. Further, it holds investments in marketable securities. The company operates eight full-service banking centers located in Leawood and Wichita, Kansas; Kansas City, Missouri; Oklahoma City and Tulsa, Oklahoma; and Dallas and Frisco, Texas. CrossFirst Bankshares, Inc. was founded in 2007 and is headquartered in Leawood, Kansas.
Earnings Per Share
As for profitability, CrossFirst Bankshares has a trailing twelve months EPS of $1.2.
PE Ratio
CrossFirst Bankshares has a trailing twelve months price to earnings ratio of 8.16. Meaning, the purchaser of the share is investing $8.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.6%.
4. Axcelis Technologies (ACLS)
16% sales growth and 30% return on equity
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Earnings Per Share
As for profitability, Axcelis Technologies has a trailing twelve months EPS of $5.76.
PE Ratio
Axcelis Technologies has a trailing twelve months price to earnings ratio of 24.74. Meaning, the purchaser of the share is investing $24.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 10.6% and 37.2%, respectively.
Yearly Top and Bottom Value
Axcelis Technologies’s stock is valued at $142.49 at 06:22 EST, below its 52-week high of $145.88 and way higher than its 52-week low of $46.41.
5. Allied Motion Technologies (AMOT)
15.2% sales growth and 10% return on equity
Allied Motion Technologies Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems that are used in a range of industries worldwide. The company offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers. It also provides electric steering actuators, steering motors, electrohydraulic pump motor, steering wheel sensor, traction wheel drives, power differentiating transaxles, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, as well as authorized manufacturers' representatives, agents, and distributors. Allied Motion Technologies Inc. was incorporated in 1962 and is headquartered in Amherst, New York.
Earnings Per Share
As for profitability, Allied Motion Technologies has a trailing twelve months EPS of $1.32.
PE Ratio
Allied Motion Technologies has a trailing twelve months price to earnings ratio of 27.61. Meaning, the purchaser of the share is investing $27.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.8%, now sitting on 533.75M for the twelve trailing months.
Moving Average
Allied Motion Technologies’s value is higher than its 50-day moving average of $36.03 and higher than its 200-day moving average of $35.37.
6. Mettler (MTD)
6.5% sales growth and 2951.46% return on equity
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labelling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Earnings Per Share
As for profitability, Mettler has a trailing twelve months EPS of $38.09.
PE Ratio
Mettler has a trailing twelve months price to earnings ratio of 34.16. Meaning, the purchaser of the share is investing $34.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2951.46%.
7. National Health Investors (NHI)
6% sales growth and 6.58% return on equity
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $2.09.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 25.12. Meaning, the purchaser of the share is investing $25.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.58%.
